Clinical Trial Update: Evaluation of Early Administration of Levetiracetam in the Prevention and Treatment Encephalopathy in Septic Shock: Randomized, Double-blind, Placebo-controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, placebo-controlled trial evaluating early administration of levetiracetam to prevent and treat encephalopathy in septic shoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Levetiracetam (Keppra) (levetiracetam)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Septic Shock | Phase 3 | Status: NOT_YET_RECRUITING